Vimarsana
Biggest News Aggregation in the World

Page 30 - Prevention Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Prevention Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Prevention Network Today - Breaking & Trending Today

What level of antibodies protect against COVID-19? Researchers are rushing to find out - Vimarsana News

What level of antibodies protect against COVID-19? Researchers are rushing to find out

What level of antibodies protect against COVID-19? Researchers are rushing to find out Elizabeth Weise, USA TODAY Replay Video UP NEXT To prove their COVID-19 vaccines worked, companies had to enroll more than 100,000 participants in monthslong clinical trials. Next time, Peter Gilbert wants such tests to require only a few hundred people and eight weeks' time. To get there, Gilbert and others have to figure out how much protection people need to avoid hospitalization and death from COVID-19, or even to prevent getting infected at all. But 15 months after COVID-19 shut down m...

Source: msn.com
5 things you need to know this Wednesday - Vimarsana News

5 things you need to know this Wednesday

5 things you need to know this Wednesday Two-week pause of phases; capital gains tax becomes law; Exclusive interview with Dr. Fauci; SR 20 reopens; TSA screening program. Author: KING 5 Staff Updated: 6:00 AM PDT May 5, 2021 Two-week pause to state’s reopening plan Gov. Jay Inslee announced a two-week pause to the state’s “Healthy Washington” reopening plan Tuesday. The pause means all counties will remain in their current phase of reopening. The state will evaluate COVID-19 data at the end of the two-week pause. Inslee said he made the decision after ...

Source: king5.com
Dr. Fauci talks with KING 5 about the Seattle doctor he asked to help develop COVID-19 vaccines - Vimarsana News

Dr. Fauci talks with KING 5 about the Seattle doctor he asked to help develop COVID-19 vaccines

Meet the Seattle doctor who Dr. Fauci trusted to help develop COVID-19 vaccines In a KING 5 exclusive interview, Dr. Anthony Fauci sits down with his friend and colleague Dr. Larry Corey of Fred Hutch. Author: Ted Land Updated: 9:30 PM PDT May 4, 2021 SEATTLE — When Dr. Anthony Fauci needed someone to help lead the effort to develop a coronavirus vaccine, he reached out to a longtime friend in Seattle, Dr. Larry Corey at Fred Hutch. They work closely together, talking almost daily about the challenges of extinguishing COVID-19 and getting more shots in people...

Source: king5.com
Barton Foundation to give $100,000 in grants to local nonprofits addressing unmet health needs - Vimarsana News

Barton Foundation to give $100,000 in grants to local nonprofits addressing unmet health needs

Submitted by paula on Thu, 04/29/2021 - 5:34pm SOUTH LAKE TAHOE, Calif. - The Barton Foundation will be issuing $100,000 in grants to nonprofits in the community who work with those facing hunger, mental health, and unmet health needs. The results of the Community Health Needs Assessment determine the areas their funds will support. Mental Health, Substance Use and Access to Care rank highest among a long list of concerns in the Lake Tahoe region. The Barton Foundation awards grants to non-profit organizations that provide support for members of the community who face these issues. ...

Regeneron's antibody drug can help prevent covid-19 from spreading among household members - Vimarsana News

Regeneron's antibody drug can help prevent covid-19 from spreading among household members

The Philadelphia Inquirer Star Tribune Vials are inspected at Regeneron Pharmaceutical’s facilities in New York state, for efforts on an experimental coronavirus antibody drug.   TribLIVE's Daily and Weekly email newsletters deliver the news you want and information you need, right to your inbox. PHILADELPHIA — Drugs that can keep high-risk covid-19 patients out of the hospital are going begging because the supposed breakthrough treatments require an hour-long intravenous infusion and offer a rather small chance of benefit. On Monday, Regeneron announced results that may help make its m...